These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28869728)

  • 1. [Application of nanobody in cancer treatment].
    Wu Y; Hao X; Li M
    Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1085-1090. PubMed ID: 28869728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INDI-integrated nanobody database for immunoinformatics.
    Deszyński P; Młokosiewicz J; Volanakis A; Jaszczyszyn I; Castellana N; Bonissone S; Ganesan R; Krawczyk K
    Nucleic Acids Res; 2022 Jan; 50(D1):D1273-D1281. PubMed ID: 34747487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on camelid nanobodies with potential application in veterinary medicine.
    Tohidi E; Ghaemi M; Golvajouei MS
    Vet Res Commun; 2024 Aug; 48(4):2051-2068. PubMed ID: 38869749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of camelidae natural nanobody phage dispaly library and screening, production and identification of anti-CD19 nanobody].
    Li G; Li Y; Chu Y; Zhang A; Pan J; Wang H; Xu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1036-1043. PubMed ID: 33210599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies as therapeutics: big opportunities for small antibodies.
    Steeland S; Vandenbroucke RE; Libert C
    Drug Discov Today; 2016 Jul; 21(7):1076-113. PubMed ID: 27080147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
    Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
    Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
    Lafaye P; Li T
    Comp Immunol Microbiol Infect Dis; 2018 Oct; 60():17-22. PubMed ID: 30396425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies.
    Zuo J; Li J; Zhang R; Xu L; Chen H; Jia X; Su Z; Zhao L; Huang X; Xie W
    BMC Genomics; 2017 Oct; 18(1):797. PubMed ID: 29041922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics.
    Mir MA; Mehraj U; Sheikh BA; Hamdani SS
    Hum Antibodies; 2020; 28(1):29-51. PubMed ID: 31322555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension.
    Fan K; Jiang B; Guan Z; He J; Yang D; Xie N; Nie G; Xie C; Yan X
    Anal Chem; 2018 May; 90(9):5671-5677. PubMed ID: 29634235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotoxins and nanobody-based immunotoxins: review and update.
    Khirehgesh MR; Sharifi J; Safari F; Akbari B
    J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical shift assignments of a camelid nanobody against aflatoxin B
    Nie Y; Li S; Zhu J; Hu R; Liu M; He T; Yang Y
    Biomol NMR Assign; 2019 Apr; 13(1):75-78. PubMed ID: 30328057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.